Joinn Laboratories(China)Co.Ltd Future Growth
Future criteria checks 3/6
Joinn Laboratories(China)Co.Ltd is forecast to grow earnings and revenue by 84.2% and 12.1% per annum respectively. EPS is expected to grow by 84.2% per annum. Return on equity is forecast to be 5.5% in 3 years.
Key information
84.2%
Earnings growth rate
84.2%
EPS growth rate
| Life Sciences earnings growth | 31.5% |
| Revenue growth rate | 12.1% |
| Future return on equity | 5.5% |
| Analyst coverage | Good |
| Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Joinn Laboratories(China)Co.,Ltd.'s (SHSE:603127) 28% Share Price Surge Not Quite Adding Up
Oct 01
Joinn Laboratories(China)Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Sep 03Joinn Laboratories(China)Co.Ltd (SHSE:603127) Is Reducing Its Dividend To CN¥0.16
Jul 28Joinn Laboratories(China)Co.,Ltd. (SHSE:603127) Analysts Just Cut Their EPS Forecasts Substantially
Apr 08There May Be Reason For Hope In Joinn Laboratories(China)Co.Ltd's (SHSE:603127) Disappointing Earnings
Apr 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,812 | 537 | 498 | 893 | 7 |
| 12/31/2025 | 2,408 | 399 | 793 | 766 | 9 |
| 12/31/2024 | 2,218 | 158 | 16 | 343 | 9 |
| 9/30/2024 | 2,125 | -1 | 136 | 367 | N/A |
| 6/30/2024 | 2,214 | 137 | 316 | 534 | N/A |
| 3/31/2024 | 2,332 | -63 | 561 | 756 | N/A |
| 12/31/2023 | 2,376 | 397 | 430 | 623 | N/A |
| 9/30/2023 | 2,579 | 770 | 435 | 641 | N/A |
| 6/30/2023 | 2,503 | 794 | 410 | 672 | N/A |
| 3/31/2023 | 2,366 | 1,137 | 624 | 882 | N/A |
| 12/31/2022 | 2,268 | 1,074 | 696 | 971 | N/A |
| 9/30/2022 | 1,936 | 941 | 680 | 1,000 | N/A |
| 6/30/2022 | 1,759 | 775 | 754 | 1,029 | N/A |
| 3/31/2022 | 1,587 | 589 | 462 | 726 | N/A |
| 12/31/2021 | 1,517 | 557 | 448 | 686 | N/A |
| 9/30/2021 | 1,301 | 419 | 506 | 668 | N/A |
| 6/30/2021 | 1,213 | 379 | 319 | 477 | N/A |
| 3/31/2021 | 1,122 | 389 | 261 | 429 | N/A |
| 12/31/2020 | 1,076 | 315 | 279 | 428 | N/A |
| 9/30/2020 | 922 | 253 | 129 | 275 | N/A |
| 6/30/2020 | 836 | 237 | 95 | 229 | N/A |
| 3/31/2020 | 720 | 194 | 38 | 166 | N/A |
| 12/31/2019 | 639 | 187 | 21 | 148 | N/A |
| 9/30/2019 | 513 | 128 | -1 | 152 | N/A |
| 6/30/2019 | 475 | 126 | 52 | 192 | N/A |
| 3/31/2019 | 432 | 112 | 59 | 185 | N/A |
| 12/31/2018 | 409 | 108 | 46 | 176 | N/A |
| 9/30/2018 | 375 | 99 | 85 | 176 | N/A |
| 6/30/2018 | 341 | 87 | N/A | 145 | N/A |
| 3/31/2018 | 334 | 92 | N/A | 136 | N/A |
| 12/31/2017 | 301 | 76 | N/A | 123 | N/A |
| 9/30/2017 | 294 | 74 | N/A | 140 | N/A |
| 12/31/2016 | 242 | 52 | N/A | 119 | N/A |
| 12/31/2015 | 207 | 49 | N/A | 106 | N/A |
| 12/31/2014 | 185 | 49 | N/A | 82 | N/A |
| 12/31/2013 | 144 | 22 | N/A | 61 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603127 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).
Earnings vs Market: 603127 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 603127 is expected to become profitable in the next 3 years.
Revenue vs Market: 603127's revenue (12.1% per year) is forecast to grow slower than the CN market (13.9% per year).
High Growth Revenue: 603127's revenue (12.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 603127's Return on Equity is forecast to be low in 3 years time (5.5%).